Quantcast
Last updated on April 17, 2014 at 12:46 EDT

Latest Orgasm Stories

2012-07-13 23:03:08

The Propecia® lawyers of OnlineLawyerSource.com are announcing that they are now offering free case reviews for men who have suffered sexual side effects after using the hair loss treatment finasteride. (PRWEB) July 13, 2012 The Propecia® lawyers of OnlineLawyerSource.com are announcing that they are now offering free case reviews for men who have persistent sexual side effects after using the male pattern hair loss treatment Propecia® (finasteride). According to the lawyers,...

2012-07-12 02:27:56

PRINCETON, N.J., July 12, 2012 /PRNewswire/ -- When it comes to the bedroom, Americans are fun, fearless and adventurous, according to new research from the makers of Trojan(TM) Brand Condoms. New findings released today as part of the Trojan®( )Charged(TM) Sex Life Survey found that while two-thirds of Americans (18 and over) are satisfied with their sex life, one in two (50 percent) feel their sex life needs a jump start. (Photo:...

2012-07-02 23:00:14

After the new premature ejaculation drug, Zertane, had a successful meeting with the FDA earlier in the week, an internet authority on treating PE without the use of drugs is announcing a new resource for men. Houston, TX. (PRWEB) July 01, 2012 MarketWatch.com has reported that a pharma company named Ampio, specializing in clinical stage biopharmaceuticals, has announced this week that its newest drug, Zertane, which treats premature ejaculation, has had a successful pre-IND meeting with...

2012-05-13 18:20:23

JERSEY CITY, N.J., May 14, 2012 /PRNewswire/ -- S1 Biopharma, an early-stage biopharmaceutical company developing therapeutic solutions for Hypoactive Sexual Desire Disorder (HSDD) and related sexual dysfunctions, today announced its foray into male sexual health with S1P-205, the first and only drug in development for male HSDD. The expansion into male sexual health represents S1 Biopharma's intent to take a comprehensive and holistic approach to treating HSDD, a clinical condition marked...

Doctor Claims He Has Discovered The G-Spot
2012-04-25 09:36:03

John Neumann for Redorbit.com Like the search for the Loch Ness Monster or sightings of UFOs, the search for the elusive G-Spot has eluded researchers ever since it was first described and named in 1950 by Ernst Grafenberg, a German gynecologist. Now, however, the mysterious spot has been identified and confirmed to be real, at least for one doctor. Writing in the Journal of Sexual Medicine, Dr. Ostrzenski of the Institute of Gynecology in St. Petersburg, Florida, said it was a...

2012-04-18 09:18:24

What makes some people give blood and bake casseroles for their neighbors, while others mutter about taxes from behind closed blinds? A new paper published in Psychological Science, a journal of the Association for Psychological Science finds that part of the answer–but not all–may be in their genes. The hormones oxytocin and vasopressin are thought to affect how people behave toward each other. For example, lab tests have found that people play nicer in economic games after...

2012-04-11 05:44:00

(Ivanhoe Newswire)-- Dialysis is a common treatment used by more then 350,000 individuals in the United States alone. Patients on dialysis commonly experience symptoms such as pain, depression, impaired sleep, and fatigue; overall impacting their quality of life. A study recently uncovered that the majority of female kidney failure patients on dialysis may also experience sexual problems. Although there is increasing awareness of erectile dysfunction in men on hemodialysis, the...

2012-04-09 02:23:33

GREENWOOD VILLAGE, Colo., April 9, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE--News) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it submitted to the FDA a pre IND package on Zertane(TM), its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US. Michael...

2012-04-06 11:01:22

4 out of 5 female dialysis patients reported sexual dysfunction Highlights:     In the largest observational study of its kind, 84% of all women and 55% of sexually active women on hemodialysis experienced sexual problems.     Sexual dysfunction was reported more often by women who were older, were less educated, had signs of depression, had reached menopause, had diabetes, and took diuretic therapy, or 'water pills.' Other studies indicate that sexual...

2012-04-02 02:27:31

GREENWOOD VILLAGE, Colo., April 2, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it reached agreement with the Therapeutic Goods Administration (TGA), Canberra, Australia, on a plan of drug manufacture and quality control for Zertane(TM)( )and the overall plan for the preparation of Common Technical...